Pfizer narrows its focus and profit soars in 3Q
Pfizer's third-quarter profit nearly doubled after it booked an $8.1 billion gain on paper by creating a consumer health products joint venture
Pfizer's third-quarter profit nearly doubled after it booked an $8.1 billion gain on paper by creating a consumer health products joint venture